Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Lung Microbiome in Innate Immune Response Associated With Chronic Lung Diseases
Keshav Raj Paudel, Vivek Dharwal, Vyoma K. Patel, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

IL-17 Cytokines and Chronic Lung Diseases
Felix Ritzmann, Lars Lunding, Robert Bals, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2132-2132
Open Access | Times Cited: 73
Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases
Sumel Ashique, Gabriele De Rubis, Ekta Sirohi, et al.
Chemico-Biological Interactions (2022) Vol. 368, pp. 110231-110231
Closed Access | Times Cited: 59
Attenuation of Cigarette-Smoke-Induced Oxidative Stress, Senescence, and Inflammation by Berberine-Loaded Liquid Crystalline Nanoparticles: In Vitro Study in 16HBE and RAW264.7 Cells
Keshav Raj Paudel, Nisha Panth, Bikash Manandhar, et al.
Antioxidants (2022) Vol. 11, Iss. 5, pp. 873-873
Open Access | Times Cited: 42
Applications and advancements of nanoparticle-based drug delivery in alleviating lung cancer and chronic obstructive pulmonary disease
Gabriele De Rubis, Keshav Raj Paudel, Leander Corrie, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2793-2833
Closed Access | Times Cited: 29
Agarwood Oil Nanoemulsion Attenuates Cigarette Smoke-Induced Inflammation and Oxidative Stress Markers in BCi-NS1.1 Airway Epithelial Cells
Gabriele De Rubis, Keshav Raj Paudel, Bikash Manandhar, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 1019-1019
Open Access | Times Cited: 26
Exploring Synergistic Interactions between Natural Compounds and Conventional Chemotherapeutic Drugs in Preclinical Models of Lung Cancer
Mihaela Boța, Lavinia Vlaia, Alex-Robert Jîjie, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 598-598
Open Access | Times Cited: 11
Keystone Bacteria Dynamics in Chronic Obstructive Pulmonary Disease (COPD): Towards Differential Diagnosis and Probiotic Candidates
Azadeh KavianFar, Hamidreza Taherkhani, Hossein Lanjanian, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42719-e42719
Open Access | Times Cited: 1
Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease
Claire Healy, Natalia Muñoz‐Wolf, Janné Strydom, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 49
Airway Microbiome and Serum Metabolomics Analysis Identify Differential Candidate Biomarkers in Allergic Rhinitis
Yuze Yuan, Chao Wang, Guoqiang Wang, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 36
Rediscovering the Therapeutic Potential of Agarwood in the Management of Chronic Inflammatory Diseases
Juman Mohammed Rasmi Alamil, Keshav Raj Paudel, Yinghan Chan, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 3038-3038
Open Access | Times Cited: 28
Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease
Alex Kayongo, Nicole Robertson, Trishul Siddharthan, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 21
A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response
Saurav Kumar Jha, Mohammad Imran, Laxmi Akhileshwar Jha, et al.
Environmental Research (2023) Vol. 236, pp. 116823-116823
Closed Access | Times Cited: 19
Microbiome as an immune regulator in health, disease, and therapeutics
Valeria M. Juarez, Alyssa N. Montalbine, Ankur Singh
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114400-114400
Open Access | Times Cited: 27
Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models
Ching Leng Tan, Yinghan Chan, Mayuren Candasamy, et al.
European Journal of Pharmacology (2022) Vol. 919, pp. 174821-174821
Closed Access | Times Cited: 22
Nasal Bacteriomes of Patients with Asthma and Allergic Rhinitis Show Unique Composition, Structure, Function and Interactions
Marcos Pérez‐Losada, Eduardo Castro‐Nallar, José Laerte Boechat, et al.
Microorganisms (2023) Vol. 11, Iss. 3, pp. 683-683
Open Access | Times Cited: 15
Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?
Vaishali Singh, Ilya V. Ulasov, Sachin Gupta, et al.
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 22-22
Open Access | Times Cited: 5
Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review
Rajan Thapa, A Magar, Jesus Shrestha, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 5
Assessment of upper respiratory and gut bacterial microbiomes during COVID-19 infection in adults: potential aerodigestive transmission
Hafez Al-Momani, Andrew Nelson, Hadeel Al Balawi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases
Meenu Mehta, Keshav Raj Paudel, Shakti D. Shukla, et al.
Journal of Controlled Release (2021) Vol. 337, pp. 629-644
Open Access | Times Cited: 31
Nutraceuticals: unlocking newer paradigms in the mitigation of inflammatory lung diseases
Yinghan Chan, Venkata Sita Rama Raju Allam, Keshav Raj Paudel, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 19, pp. 3302-3332
Closed Access | Times Cited: 28
Lung microbial-host interface through the lens of multi-omics
Shivani Singh, Jake G. Natalini, Leopoldo N. Segal
Mucosal Immunology (2022) Vol. 15, Iss. 5, pp. 837-845
Open Access | Times Cited: 22
Plant-based therapeutics for chronic obstructive pulmonary diseases: Nanoformulation strategies to overcome delivery challenges
Sofia Kokkinis, Manisha Singh, Keshav Raj Paudel, et al.
Food Bioscience (2024) Vol. 58, pp. 103761-103761
Open Access | Times Cited: 4
Clinical characteristics and risk factors of late-stage lung adenocarcinoma patients with bacterial pulmonary infection and its relationship with cellular immune function
Kangli Yang, Haiting Wei, Weiwei Zhu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Recent Advances in Chronotherapy Targeting Respiratory Diseases
Keshav Raj Paudel, Saurav Kumar Jha, Venkata Sita Rama Raju Allam, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2008-2008
Open Access | Times Cited: 24
Nutraceuticals and mitochondrial oxidative stress: bridging the gap in the management of bronchial asthma
Venkata Sita Rama Raju Allam, Keshav Raj Paudel, Gaurav Gupta, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 42, pp. 62733-62754
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top